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Background: 
Lidocaine patch (L5P) has demonstrated short-term efficacy in treating both acute surgical pain and chronic 
neuropathic pain with tolerable side effects. Percutaneous endoscopic lumbar discectomy (PELD) is the 
mainstay of minimally invasive spine surgery (MISS). Sufficient analgesia during PELD surgery makes the 
patient consider it real MISS. This study was performed to evaluate the efficacy and adverse effects of lidocaine 
patch in patients who underwent PELD under local anesthesia. 
Methods: 
L5P (L group) or placebo (P group) was randomly applied on the skin of the back covering the anticipated 
path of the working channel before 1 hour of surgery in 100 patients who underwent a single level PELD 
at L4-L5. Efficacy of the lidocaine patch was assessed by patient’s numeric rating scale (NRS) of pain at each 
stage during the surgery and by a 5-scale grading of the satisfaction with the anesthesia of the operator and 
patients after surgery. 
Results: 
Mean NRS scores at the stages of needle insertion, skin incision, serial dilation and insertion of working 
channel, and subcutaneous suture were significantly lower in the L group than the P group. Postoperative 
operator’s and patients’ satisfaction scores were also significantly higher in L group than in the P group. There 
were subtle adverse effects in both groups. 
Conclusions: 
L5P provided better pain relief during PELD, especially at the stage of needle insertion, skin incision, serial 
dilation and insertion of working channel, and subcutaneous suture. It also provided higher patient and operator 
postoperative satisfaction, with only subtle adverse effects. (Korean  J  Pain  2011;  24:  74-80)
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INTRODUCTION
    In the treatment of chronic neuropathic pain such as 
postherpetic neuralgia, lidocaine 5% patch (L5P) has dem-
onstrated short-term efficacy with tolerable side effects 
including erythema, rash, and minimal systemic absorption 
[1,2]. Trials on its use for the treatment of acute somatic 
pain in procedures such as local anesthesia for vascular 
access  procedures  and  minor  dermatological  procedures 
have been conducted [3,4]. 
    Percutaneous endoscopic lumbar discectomy (PELD) is 
a mainstay of minimally invasive spine surgery (MISS) [5]. 
Sufficient analgesia during the surgery, however, makes 
the patient feel as if it is real MISS. Therefore, it is im-
portant for the operator to recognize potential nerve dam-
age during MISS, the preferred route of performing PELD 
is under local anesthesia with intravenous analgesia rather 
than under general anesthesia accompanied with compli-
cated neural monitoring systems. In addition, it is also dif-
fi c u l t  t o  ign o r e t h e r is k s  in v o l v ed  in ge n e r a l a n es t h es i a 
s u c h  a s  a c c i d e n t a l  e x t u b a t i o n  o r  d i s p o s i t i o n  o f  e n d o -
tracheal tube during operation with the patient in prone 
position. 
    This study was designed and performed to evaluate 
the efficacy and adverse effects of the lidocaine patch in 
patients who underwent PELD. 
MATERIALS  AND  METHODS
    This study was conducted at the pain clinics at Pusan 
National University Hospital and Pusan National University 
Y angsan Hospital in Korea from March 2008 to February 
2010. The study was approved by the Policy of the Ethical 
Committee  at  Pusan  National  University  Hospital 
Institutional Review Board. All eligible patients were in-
formed about the study, and written consent was obtained 
from all participants. 
    The 100 included in the study were scheduled to re-
ceive single-level PELD at the L4-L5. They were scheduled 
for PELD due to refractory pain experienced following re-
peated epidural steroid injection, motor deficit, or cauda 
e q u i n a  s y n d r o m e .  T h e  o p e r a t o r  m a r k e d  t h e  a n t i c i p a t e d 
approach site on the skin, usually 10 cm from the midline 
before 1 day of the surgery. They were randomly allocated 
to be given either 700 mg of L5P (Lidotop patch; Teikoku 
Pharma-, Sanbonmatsu, Japan) or a placebo patch, 10 × 
14 cm in size; the 2 groups were referred to as the L and 
P groups, prospectively. The placebo patch could not be 
obtained  from  the  manufacturer  of  L5P;  therefore,  the 
patch from the manufacturer was peeled off, and the op-
posite inactive side was applied on the patients’ skin in the 
P group. Using a random-number table, the nurses ran-
domly applied a patch with its active or inactive side down 
on the skin surface marked previously by the operator be-
fore 1 hour of the surgery. To ensure tight adhesion of the 
patch to the skin, adhesive plaster was applied on top to 
cover the patch and adjacent skin in both groups. Another 
nurse removed the patch immediately after the patient en-
tered the operating room. The operator and patient were 
blind to whether the patch was applied on its active or in-
active side. 
    The PELD procedure was divided into 8 stages ac-
cording to the perceived painful events associated with it: 
(a) needle insertion; (b) discography; (c) skin incision; (d) 
serial dilation and insertion of working channel; (e) anulot-
omy; (f) discectomy; (g) radiofrequency or laser ablation 
of the ingrown nerves into the nucleus pulposus and inner 
anulus; and (h) subcutaneous suturing [6]. The pain was 
a s s e s s e d  u s i n g  a  p a t i e n t ’s  n u m e r i c  r a t i n g  s c a l e  ( N R S ) ,  
from 0 to 10, with 0 being no pain at all and 10 being 
the  worst  pain  imaginable  among  all  8  stages  during 
surgery. Operator and patient satisfaction with the anes-
t h e s i a  w a s  a s s e s s e d  b y  5  g r a d e s ,  n a m e l y ,  “excellent 
(-100%), very good (-75%), good (-50%), fair (-25%), and 
poor (-0%),” after PELD surgery. Adverse effects were al-
so recorded. 
    Conventional analgesics: (a) preoperative intravenous 
50 microgram of fentanyl and 30 mg of ketorolac, (b) pre-
operative skin and subcutaneous infiltration of 10 ml of 1% 
lidocaine, and (c) intraoperative additional intravenous in-
jection 50 μg of fentanyl with anular infiltration of 2 ml 
of 1% lidocaine before anulotomy were also administrated 
in both patient groups. 
    Statistical analysis was perf ormed using the SPSS ver. 
12 .0  f o r  W in d o w s so f t w a r e (S PS S  In c .,  Ch i c a g o , IL ).  A ll 
values were calculated as mean ± SD. Demographic char-
acteristics, such as age and sex of patients, were analyzed 
using the Student t-test and the chi-square test for the 
inter-group  comparison,  respectively.  The  mean  NRS 
score at each stage of PELD procedure was compared be-
tween groups using a Student t-test. The scaling percen-
tages given by the operator and patient on postoperative 76 Korean J Pain Vol. 24, No. 2, 2011
Table 2. The mean Numeric Rating Scale (NRS) Scores During
Percutaneous Endoscopic Lumbar Discectomy (PELD) at the L4-L5
Stages of PELD L group P group
Needle insertion
Discography
Skin incision
Serial dilation and insertion of 
 working channel 
Anulotome
Discectomy
Radiofrequency or laser ablation of 
 ingrown nerves
Subcutaneous suturing
3.5 ± 1.2*
5.5 ± 1.8
3.7 ± 1.1*
6.3 ± 2.2*
6.4 ± 2.3
3.5 ± 1.1
2.1 ± 0.5
1.7 ± 0.3*
6.3 ± 1.8
5.8 ± 2.1
6.3 ± 1.9
8.1 ± 1.4
8.3 ± 1.5
3.8 ± 1.2
2.2 ± 0.7
4.1 ± 0.5
L group: lidocaine 5% patch applied with active side down, P group:
lidocaine 5% patch applied with inactive side down. *P  ＜ 0.05, 
The mean NRS scores at the stage of needle insertion, skin incision,
serial dilation and insertion of working channel, and subcutaneous
suturing were significantly lower in the L group than in P group.
Table 1. Demographic Characteristics
Age (y) Sex (M/F)
The baseline pain intensity
(Mean NRS score)
L group
P group
53.6 ± 14.3
55.1 ± 15.4
27/23
26/24
6.9 ± 1.8
6.8 ± 1.7
There was no difference of mean age, sex distribution, and the 
baseline pain intensity between 2 groups. L group: lidocaine 5% 
patch applied with active side down, P group: lidocaine 5% patch
applied with inactive side down, NRS: numeric rating scale.
Table 3. Postoperative Patients’ and Operator’s Satisfaction
Stages of PELD L group P group
Patients’ satisfaction (%)
Operator’s satisfaction (%)
76 ± 18*
84 ± 12*
50 ± 18
56 ± 18
Five-grade sale of rating patient and operator postoperative 
satisfaction: excellent (−100%), very good (−80%), good (−60%),
fair (−40%), and poor (−20%). L group: lidocaine 5% patch applied
with active side down, P group: lidocaine 5% patch applied with 
inactive side down. *P ＜ 0.05, Postoperative patients’ and operator’s
satisfaction scores were significantly higher in the L group than 
in the P group.
satisfaction  with  the  anesthesia  were  analyzed  between 
groups using a chi-squared test. 
RESULTS
    The mean age (L: 53.6 ± 14.3 years; P: 55.1 ± 15.4 
y e a r s )  a n d  s e x  d i s t r i b u t i o n  ( L :  M / F  =  2 7 / 2 3 ;  P :  M / F  = 
26/24) were not significantly different between the L and 
P groups. The baseline pain intensity before PELD proce-
d u r e  w a s  a l s o  n o t  s i g n i f i c a n t l y  d i f f e r e n t  b e t w e e n  t h e  2 
groups, (L: 6.9 ± 1.8; P: 6.8 ± 1.7) (Table 1). 
    The mean NRS score at the stage of needle insertion, 
skin incision, serial dilation and insertion of working chan-
nel, and subcutaneous suturing was significantly lower in 
the L group in the P group (T able 2).
    The postoper ati v e patien t and oper ator satisf a ction 
scores were significantly higher in L group (76 ± 18% and 
84 ± 12% respectively) than in the P group (50 ± 18% 
and 56 ± 18% respectively) (T able 3). 
    There were subtle adverse eff ects such as skin rashes 
in 2 cases and 1 case in the L and P groups, respectively. 
DISCUSSION
    PELD is known to be a representative method of MISS. 
The operators usually consider it MISS because it involves 
a small incision, low-degree damage to the normal tissue, 
the use of local anesthesia, an early ambulation immedi-
ately after surgery, and a short hospital stay. Moreover, 
patients who have undergone PELD also consider that they 
underwent MISS until the end of the operation. Most of 
these patients have suffered from severe radicular pain for 
a considerable period, and they require treatment to alle-
viate this intractable pain. Patients may hav e the same 
impression as the operators from because of tolerable pain 
experienced during the operation that PELD is truly MISS. 
Using local anesthesia for performing PELD has a great 
merit about potential nerve damage compared to general 
anesthesia. It can also minimize the risk of accidental ex-
tubation or displacement of endotracheal tube. However, if 
the pain during the operation is too difficult to endure, pa-
tients will not perceive PELD under local anesthesia MISS. 
    In this study, applying L5P with con v entional analgesic 
m e t h o d s  g a i n e d  b o t h  o p e r a t o r  a n d  p a t i e n t  s a t i s f a c t i o n s 
with  subtle  adverse  effects  after  PELD  and  lower  pain 
scores during PELD. A considerable pain relief was shown 
at the stages of needle insertion, skin incision, serial dila-
tion and insertion of working channel, and subcutaneous 
suturing. These 4 stages are directly related to skin and 
subcutaneous  tissue  injuries.  The  needle  and  working KH Kim / Lidocaine Patch in PELD 77
Fig. 1. The anticipated passage of the needle and working channel while performing percutaneous endoscopic lumbar 
discectomy at the L4-L5. The anatomic structures from the skin to the targeted anulus at the L4-L5 intervertebral disc
space are seen in the following order from the skin surface to the disc: (1) the latissimus dorsi muscle, (2) external and
internal oblique muscle, (3) superficial thoracolumbar fascia, (4) erector spinae muscle (lateral tract: iliocostalis lumborum 
muscle), (5) deep thoracolumbar fascia, (6) quadratus lumborum muscle, (7) erector spinae muscle (lateral tract: 
intertransversarii mediales muscle), and (8) psoas major muscle. This is a case of a 37-year-old patient who underwent
single―level PELD at the L4-L5. (A) Preoperative T2-weighted sagittal magnetic resonance image (MRI); the approaching 
angle and distance from the midline were measured for the proper placement of the needle and working channel before 
PELD (B); preoperative T2-weighted axial MRI; (C) intraoperative discogram, lateral view; and (D) postoperative computed
tomography. Air shadows are seen in the passage of the working channel in the muscles (arrow) and in the anterior epidural
space after the removal of herniated nucleus pulposus using right-angled forceps (circle). 
channel  is  supposed  to  bridge  the  anatomic  structures 
from the skin to the targeted anulus at the L4-L5 inter-
vertebral disc space. The intervening structures in the fol-
lowing order are the latissimus dorsi muscle, external and 
internal oblique muscle, superficial thoracolumbar fascia, 
erector spinae muscle (lateral tract: iliocostalis lumborum 
muscle), deep thoracolumbar fascia, quadratus lumborum 
muscle,  erector  spinae  muscle  (lateral  tract:  inter-
transversarii mediales muscle), and psoas major muscle 
(Fig. 1) [7,8]. 
    Howev er, pain was not alleviated at the stages of dis-
cography, anulotomy, discectomy, and radiofrequency or 
laser ablation despite the application of L5P; this evoked 
pain may have been possibly experienced as a result of 
b u r n i n g  a n u l u s  a n d  i t s  t i g h t  a d h e s i o n  w i t h  t h e  e x i t i n g  
nerve root and irritation of the ingrown nerves into the in-
ner anulus and nucleus pulposus. However, the outcome 
according to the operator was better as no interferences 78 Korean J Pain Vol. 24, No. 2, 2011
occurred while determining pain concordance and provo-
cation, measuring the intradiscal pressure, and determin-
ing the shape of the discogram during discography. In ad-
dition, it was easy for the operator to recognize whether 
the tip of the radiofrequency or laser was located too near 
to ablate the corda equina or the nerve root during radio-
frequency or laser ablation for the ingrown nerves into the 
inner anulus and nucleus pulposus. 
    L5P is considered more effective in alleviating pain 
that is superficial than in alleviating pain that arises from 
deep somatic painful procedure. In cases of the percuta-
neous vertebroplasty or kyphoplasty, which are some other 
MISS procedures in clinical practice, the pain mainly origi-
nates deep from bone penetration of the needle and ce-
ment augmentation, and not superficially from the skin or 
subcutaneous tissue penetration of the needle. The longer 
the duration of the specific procedure and the depth of the 
passage  through  the  superficial  soft  tissue  during  this 
p r o c e d u r e  i s ,  t h e  m o r e  t h e  p a i n  t h a t  i s  e x p e r i e n c e d .  
Comparative studies taking into account the ratio of the 
depth and duration of the procedure in soft superficial tis-
sue versus in deep somatic tissue will be required to com-
pare the efficacy of L5P. 
    The most painful 2 stages during PELD in both groups 
were the serial dilation and insertion of working channel 
and the anulotomy stages. If the pain was too severe, and 
scored more than 6 in the NRS score, a small dose of pro-
pofol intravenously administered so that the patient can 
endure the remaining procedure including identification of 
the intervening the nerves. However, it is vital for the op-
erator to recognize whether the exiting nerve or the tra-
versing nerve has been intervened in a working channel 
or anulotome from the patients’ response. If the nerve has 
been intervened, it is strongly recommended to observe the 
relation between the nerve and the burning anulus through 
the endoscope. The best anesthesia during PELD is one 
that can be administered under careful monitoring, leaving 
the patient conscious, but without any discomfort pain that 
can be misconceived by the patient s as intervening nerve. 
    L5P is composed of an adhesive material containing 
5% lidocaine, which is applied to a non-woven polyester 
felt backing and covered with a polyethylene terephthalate 
(PET) film release liner. The size of the patch is 10 × 14 
cm. Each adhesive patch contains 700 mg of lidocaine (50 
mg/g adhesive) in an aqueous base. It also contains the 
following inactive ingredients: dihydroxyaluminum amino-
acetate, disodium edetate, gelatin, glycerin, kaolin, meth-
ylparaben,  polyacrylic  acid,  polyvinyl  alcohol,  propylene 
glycol, propylparaben, sodium carboxymethylcellulose, so-
dium polyacrylate, D-sorbitol, tartaric acid, and urea. The 
amount of lidocaine systemically absorbed from L5P is di-
rectly related to both the duration and the surface area 
of application. Lidocaine is metabolized rapidly by the liver 
i n t o  a  n u m b e r  o f  m e t a b o l i t e s ,  i n c l u d i n g  m o n o e t h y l g l y -
cinexylidide (MEGX) and glycinexylidide (GX), both of which 
have pharmacologic activities similar to, but less potent 
than that of lidocaine. The blood concentrations of these 
metabolites are negligible after L5P application. After in-
travenous administration of lidocaine, the serum MEGX and 
GX concentrations range from 11% to 36% and from 5% to 
11% of the original lidocaine concentrations, respectively. 
Lidocaine and its metabolites are excreted via the kidneys. 
Less  than  10%  of  lidocaine  is  excreted  without  being 
m e t a b o l i z e d .  T h e  h a l f - l i f e  o f  l i d o c a i n e  e l i m i n a t i o n  f r o m 
plasma f ollowing in tra v enous administration is 81 to 149 
minutes (mean 107 ± 22, n = 15). The systemic clearance 
is 0.33 to 0.90 L/min [9]. 
    L5P is considered more effective in neuropathic pain 
p r e s e n t e d  a s  a l l o d y n i a  r a t h e r  t h a n  s o m a t i c  p a i n  [ 1 0 ] .  
Probably, the target symptom is tactile allodynia on basis 
of the experience of L5P application in patients with post-
herpetic neuralgia. Such touch and pressure sensations are 
con d u cted in l ar ge m y e linated nerv e fi bers, su c h as Aβ 
fibers. It takes longer time to experience the loss of these 
sensations than pain and warm temperature, which are 
charged in small unmyelinated never C-fibers, after ap-
plying L5P or local infiltration of lidocaine. The 8% lido-
caine pump spray produces cutaneous topical anesthesia 
after 30 minutes, which is faster than L5P in the current 
perception threshold [11]. In cases of L5P was not applied 
prior to PELD, the alternate route migh t be to use the 
spray for accelerating the analgesic effect after patient’s 
arrival into the operating room. 
    The biggest limitation of this study was the unavail-
ability of a vehicle patch without lidocaine (placebo patch) 
similar to the actual patch itself. The tactile texture of the 
inactive side of the patch is much more different from the 
lidocaine-active side. This limitation may have confounded 
the results. However, none of patients had ever applied an 
L5P before this operation, so none of them were able to 
identify which side is active or inactive when the patch was 
applied. The other limitation was the difference in pain in-KH Kim / Lidocaine Patch in PELD 79
tensity according to the degree and direction of herniation 
of the nucleus pulposus among the eligible patients; how-
e v e r ,  e a c h  p a t i e n t  h a s  h i s / h e r  o w n  p a i n  t h r e s h o l d  t h a t 
would be different to another. The baseline pain intensity 
of the patients before the operation did not significantly 
differ between the 2 groups or appear to affect the results 
w h e n a s s es si ng p a in  in t e ns i t y c a t e g o r iz ed  i n t o d iff e r e n t 
painful stages. In this study, the PELD patients were ones 
who were experiencing refractory pain following repeated 
epidural steroid injection, motor deficit, or cauda equina 
syndrome. It would be more helpful if a future study exam-
ines the efficacy of L5P application after considering the 
cause of PELD as well, even if the causes would overlap 
in some of the patient cases. The other limitation of using 
the L5P in clinical application is insurance coverage. The 
use of L5P is only permitted for the postherpetic neuralgia. 
However, the cost of applying 1 L5P is only 1 US dollar; 
1 patch is enough to cover the anticipated passage of the 
working channel. L5P application before PELD appears to 
be a cost-effective analgesic method from the results of 
p a i n  a m e l i o r a t i o n  d u r i n g  P E L D  f r o m  t h e  p e r s p e c t i v e  o f  
both patients and operator as assessed by the satisfaction 
score they gave after PELD in this study. 
    The postoperative pain will aff ect the way patients will 
view and rate their satisfaction with PELD. However, be-
cause in most cases in this study, the patients suffered 
from radicular pain originating from herniated nucleus pul-
posus, their perception of pain was lowered postopera-
tively. Surgical injury causes flare formation around the 
wound, and results in 2 diff erent types of hyperalgesia. 
Primary hyperalgesia occurs when both thermal and me-
chanical stimuli are applied to damaged tissue close to the 
site of injury. The underlying mechanism for this pain in-
volves peripheral sensitization of primary afferent noci-
ceptors by locally released algogenic mediators. In con-
trast, ischemia may play an important role in postoperative 
pain behavior and hyperalgesia and local acidosis parallels 
them. Low pH activates several ion channels susceptible 
pain transduction, i.e., acid-sensing ion channels, vanilloid 
receptors, purinergic receptors, and potassium channels. 
Surgical  injury  also  induces  hypersensitivity  in  adjacent 
tissues, referred to as secondary hyperalgesia, and is ob-
served only when mechanical stimuli are applied to unin-
jured tissues surrounding the wound. Secondary mechan-
i c a l  h y p e r a l g e s i a  i s  c o n s i d e r e d  t o  b e  a  c o n s e q u e n c e  o f 
central sensitization and results from enhanced response 
of the dorsal horn neurons to peripheral inputs; with mag-
nitude and duration of pain corresponding to the degree 
of tissue injury [12]. The pain from a small incision of less 
than 1 cm and soft tissue injury are too small to be com-
pared with pain experienced from compressed dorsal root 
ganglion and cauda equina in PELD. The dysesthesia may 
persist in some cases, but it will have originated only from 
a detached site in the dorsal root ganglion from the herni-
ated nucleus pulposus, and it can be treated with neuro-
pathic pain medications such as anticonvulsants admin-
istration for 3 months after PELD. 
    There were subtle adverse effects of L5P application, 
such as skin erythema in 2 cases and 1 case in the L and 
P groups, respectively. There were no other potential aller-
gic or anaphylactic, and dose-related systemic reactions 
such as excitatory central nerve system and cardiovascular 
m a n i f e s t a t i o n  r e p o r t e d  i n  t h i s  s t u d y .  T h e  m a n u f a c t u r e  
recommends applying up to 3 patches, only once for up 
to 12 hours within a 24-hour period; only on intact skin 
due to anticipated variability in absorption. 
    In conclusion, L5P application 1 hour before PELD 
produced considerable relief from superficial somatic pain 
d uring th e n eedl e inserti o n, skin  incision, serial dilation 
and  insertion  of  working  channel,  and  subcutaneous 
suturing. The use of patch also resulted in a higher post-
operative  satisfaction  of  the  patients  and  operator. 
Providing additional analgesia to patients undergoing PELD 
under local anesthesia helped them to overcome subtle ad-
verse effect as well as to recognize PELD procedure as 
true MISS. From an operator’s perspective, it helped the 
operator recognize potential nerve damage during the pro-
cedure in cooperative patients.
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